Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Unity Biotechnology Inc (UBX)

Unity Biotechnology Inc (UBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Unity Biotechnology Inc 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 USA

www.unitybiotechnology.com P: 650-416-1192

Description:

UNITY Biotechnology Inc. develops therapeutics which prevents, halts and reverses various diseases. The company's product portfolio includes UBX101, is designed to treat musculoskeletal disease with an initial focus on osteoarthritis. UNITY Biotechnology Inc. is based in California, United States.

Key Statistics

Overview:

Market Capitalization, $K 27,368
Enterprise Value, $K 7,568
Shares Outstanding, K 16,790
Annual Sales, $ 0 K
Annual Net Income, $ -39,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,790 K
EBIT, $ -36,010 K
EBITDA, $ -30,020 K
60-Month Beta 0.91
% of Insider Shareholders 5.80%
% of Institutional Shareholders 29.49%
Float, K 15,816
% Float 94.20%
Short Volume Ratio 0.36

Growth:

1-Year Return -52.13%
3-Year Return -96.10%
5-Year Return -98.24%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 89.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 05/14/24
Next Earnings Date N/A
Earnings Per Share ttm -2.39
EPS Growth vs. Prev Qtr 35.85%
EPS Growth vs. Prev Year 55.26%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/20/22

UBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -104.21%
Return-on-Assets % -48.78%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.12
Book Value/Share 1.43
Interest Coverage -15.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar